Stroke recurrence in diabetics: Does control of blood glucose reduce risk?

Stroke

Volumn 28, Issue 6, 1997, Pages 1153-1157

  Alter, Milton ^a,d   Lai, Sue Min ^b   Friday, Gary ^a   Singh, Vineeta ^a   Mangesh Kumar, V ^a   Sobel, Eugene ^c  

^a ALLEGHENY UNIVERSITY HOSPITALS   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Diabetes mellitus; Glucose; Hemoglobin; Stroke prevention

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; COMORBIDITY; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; STROKE;

EID: 0031000451     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.6.1153     Document Type: Article

References (18)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA. 1979;241:2035-2038.
2. Boysen G, Nyboe J, Appleyard M, Sorensen PS, Boas J, Somnier F, Jensen G, Schnohr P. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke. 1988;19:1345-1352.
3. Barrett-Connor E, Khaw K-T. Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol. 1988;128:116-123.
4. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22: 312-318.
5. Burchfiel CM, Curb JD, Rodriguez BL, Abbott RD, Chiu D, Yano K. Glucose intolerance and 22-year stroke incidence: the Honolulu Heart Program. Stroke. 1994;25:951-957.
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
7. Lai SM, Alter M, Friday G, Sobel E. A multifactorial analysis of risk factors for recurrence of ischemic stroke. Stroke. 1994;25: 958-962.
8. Lai SM, Alter M, Friday G, Sobel E. Prognosis for survival after an initial stroke. Stroke. 1995;26:2011-2015.
9. Alter M, Friday G, Sobel E, Lai SM. The Lehigh Valley Recurrent Stroke Study: description of design and methods. Neuroepidemiology. 1993;12:241-248.
10. Goldstein DE. Is glycosylated hemoglobin clinically useful? N Engl J Med. 1984;310:384-385.
11. Whisnant JP, Wiebers DO, O'Fallon WM, Sicks JD, Frye RL. A population-based model of risk factors for ischemic stroke: Rochester, Minnesota. Neurology. 1996;47:1420-1428.
12. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Long-term risk of recurrent stroke after a first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1994;25:333-337.
13. Sacco RL, Foulkes MA, Mohr JP, Wolf PA, Hier DB, Price TR. Determinants of early recurrence of cerebral infarction: the Stroke Data Bank. Stroke. 1989;20:983-989.
14. Hier DB, Foulkes MA, Swiontoniowski M, Sacco RL, Gorelick PB, Mohr JP, Price TR, Wolf PA. Stroke recurrence within 2 years after ischemic infarction. Stroke. 1991;22:155-161.
15. Toyry JP, Niskanen LK, Lansimies EA, Partanen KPL, Uusitupa MIJ. Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependcnt diabetes mellitus. Stroke. 1996;27:1316-1318.
16. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. Non-insulin dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke. 1994;25:1157-1164.
17. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med. 1983;74:540-544.
18. Helgason CM. Current concepts of cerebrovascular disease and stroke: blood glucose and stroke. Stroke. 1988;19:1049-1053.